Updated: January 23, 2026
Combogesic Side Effects: What to Expect and When to Call Your Doctor
Author
Peter Daggett

Summarize with AI
- The Three Boxed Warnings You Must Know
- 1. Hepatotoxicity (Liver Damage)
- 2. Cardiovascular Thrombotic Events (Heart Attack and Stroke)
- 3. Serious Gastrointestinal Events (Bleeding, Ulceration, Perforation)
- Common Side Effects (Usually Mild)
- Additional Serious Side Effects to Know
- Tips to Reduce Your Risk While Taking Combogesic
Combogesic (acetaminophen/ibuprofen) carries important warnings about liver, heart, and GI risks. Here's what to watch for and when to seek medical help.
Combogesic (acetaminophen and ibuprofen) is an effective prescription pain reliever — but like all medications, it carries risks that every patient should understand before taking it. This guide covers both common side effects (the ones most people experience) and serious side effects (rarer but requiring immediate medical attention).
The Three Boxed Warnings You Must Know
Combogesic's FDA label includes a "black box" warning — the FDA's most serious safety alert — covering three risk categories:
1. Hepatotoxicity (Liver Damage)
Acetaminophen, one of the two active ingredients in Combogesic, can cause acute liver failure — sometimes requiring liver transplant and, in severe cases, resulting in death. This risk is most associated with doses exceeding 4,000 mg of acetaminophen per day from all sources.
Critical point: Many OTC medications — cold medicines, flu remedies, sleep aids — also contain acetaminophen. Always check the labels of everything you're taking. Do NOT combine Combogesic with Tylenol, NyQuil, Theraflu, Excedrin, or any other acetaminophen-containing product unless your doctor specifically tells you to.
Call your doctor or go to the ER if you experience: dark or tea-colored urine, yellowing of the skin or whites of the eyes (jaundice), pain in the upper right side of your abdomen, unusual fatigue, or nausea/vomiting without an obvious cause.
2. Cardiovascular Thrombotic Events (Heart Attack and Stroke)
Ibuprofen, the NSAID component of Combogesic, increases the risk of serious cardiovascular thrombotic events, including heart attack and stroke. This risk can occur even early in treatment and increases with:
Higher doses of Combogesic
Longer duration of use
Pre-existing cardiovascular disease or risk factors (high blood pressure, high cholesterol, diabetes, smoking)
Combogesic is also contraindicated for perioperative pain management in the setting of CABG (coronary artery bypass graft) surgery.
Seek emergency care if you experience: chest pain or tightness, sudden shortness of breath, sudden weakness or numbness on one side of the body, sudden severe headache, or sudden vision changes — these could be signs of a heart attack or stroke.
3. Serious Gastrointestinal Events (Bleeding, Ulceration, Perforation)
NSAIDs like ibuprofen can cause serious GI bleeding, stomach ulcers, and intestinal perforation — these can occur without warning symptoms. Risk is higher in:
Patients over 65 years of age
Those with a prior history of stomach ulcers or GI bleeding
Patients also taking blood thinners (warfarin), aspirin, SSRIs/SNRIs, or corticosteroids
Contact your doctor immediately if you notice: black or tarry stools, vomiting blood or material that looks like coffee grounds, stomach pain that gets worse over time, or significant abdominal tenderness.
Common Side Effects (Usually Mild)
The most frequently reported side effects from Combogesic clinical studies include:
Nausea
Vomiting
Dizziness
Headache
Constipation
Mild sleepiness (reported in approximately 2% of clinical trial patients)
For IV form: infusion site pain and infusion site extravasation (leakage into surrounding tissue)
Additional Serious Side Effects to Know
Serious skin reactions: Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) have been reported. Stop taking Combogesic and seek emergency care if you develop a skin rash, blistering, peeling skin, sores in your mouth or eyes, or high fever alongside a rash.
Kidney problems: Ibuprofen can reduce kidney function, particularly in patients who are dehydrated, elderly, or have pre-existing kidney disease. Combogesic is not recommended in patients with renal impairment.
Anaphylaxis: Rare but life-threatening allergic reactions have been reported with NSAIDs. Stop taking Combogesic and seek emergency help if you experience difficulty breathing, facial swelling, or rapid heartbeat.
Tips to Reduce Your Risk While Taking Combogesic
Take with food or milk to reduce stomach upset.
Check every OTC product label for acetaminophen before taking it.
Avoid alcohol — it increases liver and GI bleeding risk.
Use the lowest effective dose for the shortest time needed — Combogesic is indicated for short-term acute pain management only.
Tell every provider and pharmacist that you're taking Combogesic — many drug interactions are caused by duplicating acetaminophen or NSAID content unknowingly.
For a full list of drug interactions, see our post: Combogesic Drug Interactions: What to Avoid and What to Tell Your Doctor.
Frequently Asked Questions
The most commonly reported side effects in Combogesic clinical trials include nausea, vomiting, dizziness, headache, constipation, and mild drowsiness. For the IV form, infusion site pain and extravasation were also commonly reported. Most common side effects are mild and resolve on their own.
Yes — acetaminophen overdose can cause serious liver damage or acute liver failure. The risk is greatest when total daily acetaminophen from all sources exceeds 4,000 mg. Do not combine Combogesic with any other product containing acetaminophen (Tylenol, NyQuil, Theraflu, etc.) without your doctor's guidance.
Warning signs of serious GI bleeding include black or tarry stools, vomiting blood or material resembling coffee grounds, persistent stomach pain, and dizziness or lightheadedness. These can occur without prior warning symptoms. Seek immediate medical attention if you notice any of these signs.
Elderly patients are at higher risk for NSAID-related cardiovascular, gastrointestinal, and kidney adverse events, and for acetaminophen-related liver toxicity. Combogesic should be used with extra caution in patients over 65, and many clinicians use a lower target dose for elderly patients. Always discuss with the prescribing doctor.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Combogesic also looked for:
More about Combogesic
31,889 have already found their meds with Medfinder.
Start your search today.





